This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Monday, July 11, 2016
Epclusa among hepatitis drugs that are medical miracles of the 21st century
Dr. Bill Elliott: Epclusa among hepatitis drugs that are medical miracles of the 21st century
Last week the Food and Drug Administration approved a new drug to treat hepatitis C. The approval did not receive much fanfare in the lay press maybe because the new drug is similar to several other medications that are already on the market....
The progress on hepatitis C, however, has been nothing short of miraculous. With the approval of Epclusa along with its cousin medications Harvoni, Viekira Pak and Technivie, we are now able to cure most patients infected with hepatitis C — one of the true medical miracles of the 21st century. These drugs are expensive and need to be given by experts, but virtually anyone infected with hepatitis C is now a candidate for treatment...
No comments:
Post a Comment